NCT01191749 2017-05-09Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)M.D. Anderson Cancer CenterPhase 2 Terminated7 enrolled 6 charts